Sinopharm Group (01093.HK): Wei Qingjie appointed as Vice Chairman, Executive Director, and Chief Operating Officer of the company.

The Smart Finance and Economics APP news, Shiyao Group (01093.HK) announced that, effective from December 19, 2025: Mr. Zhang Cuilong will no longer serve as the Vice Chairman of the Board, Chief Executive Officer of the company, and the authorized representative of the company under Rule 3.05 of the Securities Listing Rules of the Hong Kong Stock Exchange due to a job transfer, but will continue to serve as an executive director of the company; Dr. Cai Lei has been appointed as Vice Chairman, Executive Director, Chief Executive Officer, and authorized representative of the company; Mr. Wei Qingjie has been appointed as Vice Chairman, Executive Director, and Chief Operating Officer of the company.